Information From Your Health Care Provider
PROSTATIC HYPERPLASIA, BENIGN BASIC INFORMATION DESCRIPTION Enlargement of the prostate gland. The prostate is about the size of a walnut and is located just below the urinary bladder in men. An enlarged prostate presses against the urethra (tube that carries urine outside) making it narrower. The bladder muscle becomes thicker and more sensitive, causing a need to urinate more often. BPH occurs more often in men over age 50. FREQUENT SIGNS AND SYMPTOMS
Increased urinary urgency and frequency, especially at night.
Stopping and starting again while urinating.
Straining and dribbling during urination.
Feeling that the bladder cannot be emptied completely.
Leaking of urine and sometimes blood in the urine. CAUSES Exact cause unknown. It is common for the prostate to enlarge as a man ages. RISK INCREASES WITH Aging. PREVENTIVE MEASURES No specific prevention measures are known. EXPECTED OUTCOMES Symptoms may improve, worsen, or stay the same. A variety of treatments are available that can help to relieve the symptoms. POSSIBLE COMPLICATIONS DIAGNOSIS & TREATMENT GENERAL MEASURES
Your health care provider will do a digital rectal exam (DRE). During a DRE, a gloved, lubricated finger is inserted into the rectum to feel the prostate
gland's size and to check for lumps. Blood levels of prostate-specific antigen (PSA) will be checked. Other medical tests may include urine flow rate
study, urinalysis, urine culture, X-ray of the urinary tract, and ultrasound.
A question and answer interview is done about your symptoms. This can help in making treatment decisions. After treatment, it provides a good idea of
how much the symptoms have improved.
Treatment may include nonsurgical treatment, surgery, or drugs. Emergency treatment may be needed if all urine output is blocked.
Watchful waiting is an option. This means monitoring the symptoms for a time before deciding on treatment.
Several types of nonsurgical procedures are available. They include balloon dilation, prostatic stents, microwave therapy, needle ablation using
radiofrequency, electrovaporization, and laser therapy. Your health care provider will explain and discuss these options.
Surgery may be recommended if there are more severe symptoms, complications occur, or there is a health risk. Several surgical options are available.
The choice usually depends upon the size of the enlarged prostate. Surgery removes the enlarged part of the prostate. The rest is left intact. MEDICATIONS
Finasteride or dutasteride may be prescribed. They cause the prostate to shrink.
Alpha-adrenergic blockers may be prescribed. They help relax the muscles in the prostate.
Antibiotics may be prescribed if you develop a urinary-tract infection.
Read labels on all nonprescription drugs. Avoid those that state "not recommended if you have prostatic hypertrophy". Examples are antidiarrheals and
ACTIVITY No limits on activities. DIET No special diet. Avoid spicy foods and pepper, which irritate the urethra. NOTIFY OUR OFFICE IF
You or a family member has symptoms of BPH.
During treatment, any sign of urinary-tract infection occurs. This includes frequent, difficult, or painful urination, fever and chills, aching around the
New, unexplained symptoms develop. Drugs used in treatment may produce side effects.
Any symptoms develop following surgery.
Europass Curriculum Vitae Personal information Surname(s) / First name(s) Ferrucci Andrea Address(es) via Apollo Pizio, num. 3 – 00135 Rome Occupational field Cardiologist Work experience Occupation or position held MD, specialist in cardiology Main activities and responsibilities Clinical Management of High-Risk patients, Hypertension Unit, Division of Cardiology
Keywords for FP7 thematic areas Nanotechnology Topics Covered: Nanoscience and nanotechnology, Biodegradable nanostructured material, Sustainable Energy Conversion, Thin films, Nanotubes, Nanofibers, Nanotechnology based materials and products, Biomaterials and bio-inspired materials, Integration of knowledge and technology. "nanotextiles", "nanoelectromechanical systems"